Ranibizumab 0.5mg
You Searched
₹19,990


WHO GMP
Certified

Long Expiry
(>8 Months)

WHO GMP
Certified

Long Expiry
(>8 Months)
In Diabetic eye disease : Diabetic eye disease is a group of eye problems seen in people with diabetes. It can lead to vision loss, weak eyesight or even blindness. Ranizurel 0.5mg Injection helps prevent this damage caused by diabetes and stops the worsening of vision. Consult your doctor if you have any doubts.In Wet age-related macular degeneration Macula is the part of the retina responsible for central vision. Wet age-related macular degeneration is an eye disorder that causes blurred vision or a blind spot in your visual field due to abnormal blood vessels that leak fluid or blood into the macula. This leads to vision problems. Ranizurel 0.5mg Injection helps prevent leakage of such abnormal blood vessels and therefore prevents vision loss. It is given as an injection by a doctor or nurse and should not be self-administered.In Macular edema due to retinal vein occlusion
Side effects of Ranizurel Injection The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Ranizurel Conjunctival hemorrhage Eye pain Increased intraocular pressure Foreign body sensation in eyes Blurred vision Nausea Dry eye Eye itching Cataract Vitreous floaters Vitreous detachment Intraocular inflammation Eye irritation
How to use Ranizurel Injection Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Ranizurel Injection works Ranizurel 0.5mg Injection is an anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the growth and leakage of abnormal blood vessels in the eye(s) that may cause vision loss.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Ranizurel 0.5mg Injection . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Ranizurel 0.5mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Ranizurel 0.5mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Ranizurel 0.5mg Injection may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Ranizurel 0.5mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Ranizurel 0.5mg Injection may not be needed in these patients. Doctor consultation is advised.
Ranizurel 0.5mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Ranizurel 0.5mg Injection may not be needed in these patients. Please consult your doctor.
If a dose of Ranizurel 0.5mg Injection is missed, it's advisable to consult your doctor.
Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane-Belapur Road, Rabale, Navi Mumbai 400 701
Henderer JD, Rapuano CJ. Ocular Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1794
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1196-97
Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 977
Drugs.com. Ranibizumab (04 Apr. 2019)
Ranibizumab. South San Francisco, California: Genentech, Inc.; 2006 (23 Jan. 2019)
Ranibizumab. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2007 (04 Apr. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.